TCRX

Tscan Therapeutics Inc

Jun 22 • 04:00PM ET

0.8710

-0.0490 -5.33 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: ANVS EXOZ FBIO ICCC MCRB PLRX PMVP QTTB RLYB XBIT

| Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.96	Insider Own	14.15%	Shs Outstand	65.35M	Perf Week	-4.51%
Market Cap	56.92M	Forward P/E	-	EPS next Y	-0.97	Insider Trans	1.78%	Shs Float	56.10M	Perf Month	-12.43%
Enterprise Value	21.40M	PEG	-	EPS next Q	-0.26	Inst Own	47.86%	Short Float	1.67%	Perf Quarter	-16.25%
Income	-124.31M	P/S	6.23	EPS this Y	-5.40%	Inst Trans	1.88%	Short Ratio	1.16	Perf Half Y	-6.20%
Sales	9.14M	P/B	0.54	EPS next Y	8.35%	ROA	-46.50%	Short Interest	0.93M	Perf YTD	-12.90%
Book/sh	1.61	P/C	0.44	EPS next 5Y	5.09%	ROE	-80.95%	52W High	2.57 -66.11%	Perf Year	-39.51%
Cash/sh	1.96	P/FCF	-	EPS past 3/5Y	28.66% 2.08%	ROIC	-68.29%	52W Low	0.85 2.70%	Perf 3Y	-69.22%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-8.63% 56.92%	Gross Margin	68.48%	Volatility	8.54% 7.12%	Perf 5Y	-
Dividend TTM	-	EV/Sales	2.34	EPS Y/Y TTM	12.20%	Oper. Margin	-1408.73%	ATR (14)	0.08	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	6.65	Sales Y/Y TTM	106.65%	Profit Margin	-1360.61%	RSI (14)	37.77	Recom	1.33
Dividend Gr. 3/5Y	- -	Current Ratio	6.65	EPS Q/Q	16.19%	SMA20	-10.79%	Beta	1.05	Target Price	6.00
Payout	-	Debt/Eq	0.95	Sales Q/Q	-54.77%	SMA50	-19.70%	Rel Volume	2.01	Prev Close	0.92
Employees	142	LT Debt/Eq	0.88	Earnings	May 06 BMO	SMA200	-30.98%	Avg Volume	804.02K	Price	0.87
IPO	Jul 16, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	-8.64% -60.72%	Trades		Volume	1,613,838	Change	-5.33%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)